Portman Square Capital LLP Dexcom Inc Put Options Transaction History

Portman Square Capital LLP

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Jan 19, 2024	SELL	$75.49 - $124.16 $5.18 Million - $8.52 Million	-68,600 Reduced 51.7%	64,100 $7.95 Million
Q3 2023 Oct 30, 2023	BUY	$86.06 - $137.93 $7.07 Million - $11.3 Million	82,200 Added 162.77%	132,700 $12.4 Million
Q2 2023 Jul 26, 2023	BUY	$112.47 - $130.98 $5.68 Million - $6.61 Million	50,500 New	50,500 $6.49 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Portman Square Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Portman Square Capital LLP with notifications on news.